U.S. Healthcare Services Stock News

Merck (MRK) shares have seen notable swings recently, leaving investors curious about what might be driving the movement. Looking at recent performance trends, Merck’s returns over the past month and past 3 months provide some perspective on its current trajectory. See our latest analysis for Merck. Zooming out, Merck’s share price return over the past year has been fairly muted, trailing many peers as momentum has faded following more robust earlier performance. However, with steady long-run...

Recently, Delek Logistics Partners, L.P. was upgraded to a Zacks Rank #2 (Buy), reflecting an improved outlook as analysts have raised earnings estimates steadily over the past three months. This upgrade highlights growing analyst confidence in Delek Logistics' financial prospects, linked to rising earnings expectations and positive sentiment among market observers. We'll explore how this analyst-fueled confidence may influence Delek Logistics Partners' investment narrative and growth...

Stifel Financial (SF) has shown a steady pattern in recent trading, and its performance over the past year has caught the attention of investors interested in financial sector value plays. The company’s long-term returns remain a focus. See our latest analysis for Stifel Financial. Stifel Financial’s share price has seen only mild moves lately, but the bigger picture is much more compelling. While the most recent price activity has been quiet, the stock’s 1-year total shareholder return of...

Arcellx (ACLX) has found itself in the spotlight as recent analyst commentary points to a more favorable regulatory setting and increased investor attention on its anti-cel therapy compared with Johnson & Johnson’s Carvykti. The conversation around these therapies continues to shape how investors assess the stock’s potential. See our latest analysis for Arcellx. Momentum around Arcellx has picked up lately as renewed confidence in its regulatory footing and therapy pipeline keeps the...

RBC Capital has just initiated coverage on Apogee Therapeutics (APGE), highlighting the company’s promising Phase II results in atopic dermatitis and its broader efforts in inflammation and immunology research. This move attracted fresh investor attention. See our latest analysis for Apogee Therapeutics. The fresh momentum around Apogee Therapeutics is not just about the latest analyst coverage; after a sluggish stretch in 2024, signs of renewed optimism are surfacing. While the 1-year total...

Firefly Aerospace (FLY) saw its stock drop sharply after the first stage of its Alpha Flight 7 rocket exploded during a preflight test in late September. The timing, coming just weeks ahead of a planned launch, has deepened investor uncertainty around Firefly’s commercial reliability and future schedule. See our latest analysis for Firefly Aerospace. Firefly Aerospace’s volatile ride since its August IPO has only accelerated with recent events. While the company wowed markets out of the gate,...

Curtiss-Wright (CW) shares have caught the eye of investors recently, as the company's stock has delivered a strong year-to-date performance and outpaced broader market returns over the past year. With steady revenue and net income growth, many are taking a closer look at CW's momentum in the current market environment. See our latest analysis for Curtiss-Wright. Curtiss-Wright’s share price has pressed higher this year, and its 1-year total shareholder return of nearly 60% stands out against...

AerCap Holdings (AER) shares moved modestly higher this week, building on a steady climb over the past month. The company’s year-to-date performance now exceeds 28%, reflecting ongoing interest from investors tracking capital goods stocks. See our latest analysis for AerCap Holdings. AerCap’s momentum has been gradually gathering steam, with its share price pushing higher this year as a result of resilient demand for aircraft leasing and sector stability. The company’s 1-year total...

Plug Power (PLUG) just delivered its first 10-megawatt GenEco electrolyzer array to Galp’s Sines Refinery in Portugal. This delivery marks the beginning of a 100-megawatt green hydrogen project that ranks among Europe’s largest. See our latest analysis for Plug Power. The buzz around Plug Power’s breakthrough with the Galp electrolyzer delivery comes on the heels of some big recent announcements, including new cost-cutting goals, a ramp-up in green hydrogen output, and an expanded $1 billion...

Shares of Waters (WAT) have attracted fresh attention after reports surfaced about a potential drug-pricing agreement between the White House and pharmaceutical companies. The deal aims to give the industry clearer regulatory signals regarding future pricing. See our latest analysis for Waters. Waters has seen only modest moves this year, hovering near a share price of $321.92 as headlines around drug-pricing reform and its recent earnings schedules played out. While the year’s share price...

Danaher (NYSE:DHR) shares have climbed after its subsidiary, Leica Biosystems, rolled out new AI-powered digital pathology solutions. The move comes at a time when the US is introducing substantial tariffs on imported pharmaceuticals, which could give domestic producers, including Danaher, a competitive edge. See our latest analysis for Danaher. Danaher’s recent buzz has brought renewed attention to the stock, which has managed a modest upswing amidst a backdrop of innovation and shifting...

FedEx recently launched a new direct air cargo route between Dublin and its Indianapolis hub, operating four times weekly to expedite high-value and healthcare shipments by bypassing congested U.S. East Coast gateways. This development highlights FedEx's ongoing focus on expanding its international logistics footprint and facilitating cross-Atlantic trade between key pharmaceutical regions in Ireland and the U.S. We'll explore how FedEx's enhanced transatlantic network could influence its...

In recent weeks, Organon has captured investor attention as the company prepares for its upcoming earnings release, which is projected to show year-over-year growth amid notable changes in analyst sentiment and valuation metrics. This heightened focus on Organon's earnings potential highlights the market's sensitivity to evolving analyst estimates and expectations for future financial performance. We'll examine how anticipation over Organon's upcoming earnings release and analyst estimate...

Liberty Global (LBTY.A) shares have shifted recently, piquing investor interest as the company’s performance trends moderately upward over the past month. Many are watching to see if these moves hint at longer-term momentum. See our latest analysis for Liberty Global. After months of modest movement, Liberty Global’s share price is showing early signs of rejuvenation, helped by recent developments that have caught market attention. Although this year’s share price return has been slightly...

Diodes Incorporated recently introduced the AL58818Q and AL58812Q, automotive-compliant LED drivers designed for precise color mixing, brightness control, and advanced lighting effects, targeting applications in automotive lighting, infotainment displays, and interior ambience. This launch highlights Diodes' emphasis on expanding its automotive-grade LED solutions, aiming to serve more complex, energy-efficient lighting needs within next-generation vehicles and related electronic...

BXP completed a private offering of US$600 million in exchangeable senior notes and secured US$465 million in refinancing for The Hub on Causeway, reflecting significant recent capital activity. These actions highlight BXP’s efforts to bolster liquidity and optimize its debt profile, which could shape the company’s position for future growth and development projects. We’ll explore how BXP’s substantial note issuance signals a focus on financial flexibility and influences the company’s...

In late September 2025, The Hartford Insurance Group finalized a Second Amended and Restated Credit Agreement, securing a US$750 million revolving credit facility and the option to access up to an additional US$500 million, backed by major banking institutions. At the same time, the company rolled out its CyberChoice First Response insurance product nationwide for small businesses (excluding three states), indicating a coordinated effort to both expand liquidity and address growing demand...

Key Insights Given the large stake in the stock by institutions, Zentalis Pharmaceuticals' stock price might be...

Ellomay Capital (NYSEAM:ELLO) remains unprofitable, with no evidence of a positive net profit margin or high-quality past earnings, but has managed to reduce its losses by an average of 4.7% per year over the past five years. While investors may note the company's progress on trimming losses, ongoing concerns around financial stability and a premium valuation compared to the industry average may weigh on sentiment. See our full analysis for Ellomay Capital. Next, we will see how the latest...

In recent days, Clearwater Analytics Holdings received bullish analyst commentary spotlighting new product innovation, strategic acquisitions, and operational advancements, alongside showcasing its vision for the industry's first unified investment management platform at the Clearwater Connect 2025 conference. An interesting insight is that Clearwater Analytics surpassed its 80% gross margin milestone ahead of schedule, while securing new institutional clients and expanding solutions for...

Just because a business does not make any money, does not mean that the stock will go down. By way of example, Kodiak...

Tilray Brands, Inc. ( NASDAQ:TLRY ) shares have continued their recent momentum with a 29% gain in the last month...

Four Corners Property Trust (FCPT) has made headlines with a string of acquisitions, picking up automotive service centers and veterinary properties in recent weeks. The company is broadening its portfolio and moving beyond its foundation in restaurant assets. See our latest analysis for Four Corners Property Trust. All these recent acquisitions highlight FCPT’s push to diversify and strengthen its portfolio, but even with robust deal activity, the share price recently touched a 52-week low...

CTS (NYSE:CTS) has just introduced COBROS, a new electric motor control platform that uses in-situ magnetic field sensing to simplify designs and boost efficiency. This innovation could prompt investors to reevaluate the company’s growth potential. See our latest analysis for CTS. The recent launch of COBROS arrives during a tougher spell for CTS, with a 90-day share price return of -10.9% and the latest close at $39.75. However, the company's five-year total shareholder return of 62.9% still...